Diffuse large B-cell lymphoma: reduced CD20 expression is associated with an inferior survival

CD19 and CD20 are B cell–specific antigens whose expression is heterogeneous when analyzed by flow cytometry (FCM). We determined the association between CD20 expression and clinical outcome in patients with diffuse large B-cell lymphoma (DLBCL). The mean fluorescence intensity of CD20 and CD19 was...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Johnson, Nathalie A., Boyle, Merrill, Bashashati, Ali, Leach, Stephen, Brooks-Wilson, Angela, Sehn, Laurie H., Chhanabhai, Mukesh, Brinkman, Ryan R., Connors, Joseph M., Weng, Andrew P., Gascoyne, Randy D.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2009
Assuntos:
Lymphoid Neoplasia
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2943836/
https://ncbi.nlm.nih.gov/pubmed/19029441
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2008-09-177469
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados